RAD51 135G>C polymorphism and risk of sporadic colorectal cancer in Iranian population

被引:8
|
作者
Yazdanpanahi, Nasrin [1 ]
Salehi, Rasoul [2 ]
Kamali, Sara [2 ]
机构
[1] Islamic Azad Univ, Falavarjan Branch, Dept Genet, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Dept Genet & Mol Biol, Esfahan, Iran
关键词
Iran; RAD51 135G>C polymorphism; sporadic colorectal cancer; SINGLE NUCLEOTIDE POLYMORPHISM; DOUBLE-STRAND BREAKS; GENE; PROTEIN; REPAIR; INSTABILITY; CARRIERS;
D O I
10.4103/0973-1482.183558
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Aim of Study: Colorectal cancer (CRC) is among the most common cancers and accounts as the second leading cause of death from cancers in the world. RAD51 plays a crucial role in double-strand breaks repair of DNA. Single nucleotide polymorphisms within this gene could influence on the potential of DNA repair and in consequence on the susceptibility to various tumors such as CRC. This is the first report about the role of RAD51 polymorphisms in Iranian CRC susceptibility. The study was conducted to evaluate the association of 135G>C polymorphism of RAD51 gene with sporadic CRC in a subset of Iranian population. Materials and Methods: The current case-control study was performed from 2013 to 2015. One hundred patients with sporadic CRC and one hundred controls were enrolled from two referral centers in Isfahan. All samples were genotyped for the RAD51 gene using polymerase chain reaction-restriction fragment length polymorphism assay. Results: The results revealed no significant association between the RAD51 135G>C and sporadic CRC (odds ratio = 0.86, 95% confidence interval = 0.464-1.595). The frequency of genotypes and also alleles of the mentioned polymorphism were not significantly different between case and control groups (P = 0.2 and 0.4, respectively). Conclusion: The results suggest that RAD51 135G> C probably has not a crucial role in Iranian CRC risk and is not an important potential risk factor in molecular diagnostics of mentioned disease among Iranian population.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 50 条
  • [1] RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis
    Zhou, Guo-Wu
    Hu, Jia
    Peng, Xu-Dong
    Li, Qiang
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 529 - 535
  • [2] 135G>C AND 172G>T POLYMORPHISM IN THE 5′ UNTRANSLATED REGION OF RAD51 AND SPORADIC ENDOMETRIAL CANCER RISK IN POLISH WOMEN
    Smolarz, Beata
    Samulak, Dariusz
    Michalska, Magdalena
    Goralczyk, Bozena
    Szyllo, Krzysztof
    Lewy, Jaroslaw
    Sporny, Stanislaw
    Kokolaszwili, Grzegorz
    Burzynski, Marek
    Romanowicz-Makowska, Hanna
    POLISH JOURNAL OF PATHOLOGY, 2011, 62 (03) : 157 - 162
  • [3] New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk
    Lu, Pei-Hua
    Chen, Min-Bin
    Shen, Wei
    Li, Chen
    Wu, Ming-Yu
    Tao, Guo-Qing
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 265 - 266
  • [4] The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
    Leifler, K. Soderlund
    Asklid, A.
    Fornander, T.
    Askmalm, M. Stenmark
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 797 - 804
  • [5] RAD51 135G>C polymorphism in esophageal cancer and meta-analysis in gastrointestinal tract cancers
    Bali, Jagmohan Singh
    Sambyal, Vasudha
    Guleria, Kamlesh
    Mehrotra, Sanjana
    Singh, Neeti Rajan
    Uppal, Manjit Singh
    Manjari, Mridu
    Sudan, Meena
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S273 - S279
  • [6] RAD51 135G > C polymorphism and risk of familial breast cancer in a South American population
    Jara, Lilian
    Acevedo, Monica L.
    Blanco, Rafael
    Castro, Victor G.
    Bravo, Teresa
    Gomez, Fernando
    Waugh, Enrique
    Peralta, Octavio
    Cabrera, Elsa
    Reyes, Jose M.
    Ampuero, Sandra
    Gonzalez-Hormazabal, Patricio
    CANCER GENETICS AND CYTOGENETICS, 2007, 178 (01) : 65 - 69
  • [7] RAD51 G135C gene polymorphism and risk of colorectal cancer in Kashmir
    Nissar, Saniya
    Baba, Shahid M.
    Akhtar, Tahseena
    Rasool, Roohi
    Shah, Zaffar A.
    Sameer, Aga Syed
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2014, 23 (04) : 264 - 268
  • [8] Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk
    He, Xiao-Feng
    Su, Jiao
    Zhang, Ying
    Ding, Da-Peng
    Wang, Wei
    Liu, Yi
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 649 - 651
  • [9] RAD51 135 G>C polymorphism and risk for ovarian cancer in Serbian women
    Jankovic, Radmila
    Malisic, Emina
    Krivokuca, Ana
    Boijevic, Ivana
    Redulovic, Sinisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion
    Yu, Ke-Da
    Li, Bin
    Zhou, Ying
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) : 297 - 299